Trial Outcomes & Findings for Fetal Neurobehavior in Non-methadone Maintained Women in Substance Abuse Treatment (NCT NCT00522626)

NCT ID: NCT00522626

Last Updated: 2016-03-01

Results Overview

Fetal heart rate in beats per minute

Recruitment status

COMPLETED

Target enrollment

19 participants

Primary outcome timeframe

60 minutes

Results posted on

2016-03-01

Participant Flow

Enrollment occured between May 2006 and May 2009 from a drug treatment facility treating pregnant and postpartum drug dependent women

Participant milestones

Participant milestones
Measure
Observational
Opioid exposed pregnancies
Overall Study
STARTED
19
Overall Study
COMPLETED
12
Overall Study
NOT COMPLETED
7

Reasons for withdrawal

Reasons for withdrawal
Measure
Observational
Opioid exposed pregnancies
Overall Study
Lost to Follow-up
7

Baseline Characteristics

Fetal Neurobehavior in Non-methadone Maintained Women in Substance Abuse Treatment

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Observational
n=19 Participants
Opioid exposed pregnancies
Age, Continuous
30.25 years
STANDARD_DEVIATION 7.38 • n=5 Participants
Sex: Female, Male
Female
19 Participants
n=5 Participants
Sex: Female, Male
Male
0 Participants
n=5 Participants
Region of Enrollment
United States
19 participants
n=5 Participants

PRIMARY outcome

Timeframe: 60 minutes

Population: Total number of subjects completing assessment

Fetal heart rate in beats per minute

Outcome measures

Outcome measures
Measure
Trough Fetal Heart Rate
n=12 Participants
Opioid exposed pregnancies
Fetal Heart Rate
142.34 beats per minute
Standard Deviation 10.60

SECONDARY outcome

Timeframe: 120 minutes

Outcome measures

Outcome data not reported

Adverse Events

Observational

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Lauren Jansson

Johns Hopkins University School of Medicine

Phone: 410-550-5438

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place